Phase 1 Trial of Flavopiridol in Combination With Lenalidomide in Patients With Relapsed or Refractory B-Cell CLL/SLL
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2015
At a glance
- Drugs Lenalidomide (Primary) ; Alvocidib
- Indications B cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Mar 2013 Planned end date changed from 1 Jan 2100 to 1 Dec 2013 as reported by ClinicalTrials.gov.